Detomidine HCl 90038-01-0 Inhibitor Neuronal mgbaàmà analgesic
Ụgwọ:T/T, L/C
Isi mmalite ngwaahịa:China
Ọdụ ụgbọ mmiri:Beijing/Shanghai/Hangzhou
Ike mmepụta:50kg / ọnwa
Nye iwu (MOQ):25kg
Etiti oge:3 ụbọchị ọrụ
Ọnọdụ nchekwa:A na-echekwa ya na ebe dị jụụ na nke kpọrọ nkụ, mechie ya ma zere ìhè.
Ihe ngwugwu:drum
Nha ngwugwu:25kg / agba
Ozi nchekwa:Ọ bụghị ngwongwo dị ize ndụ
Okwu mmalite
Detomidine bụ ihe na-emepụta imidazole na α2-adrenergic agonist, nke a na-eji dị ka nnukwu anụ ahụ na-edozi ahụ, nke a na-ejikarị na ịnyịnya.
Detomidine bụ ihe na-edozi ahụ nke nwere ihe analgesic α2-adrenergic agonists na-emepụta dose-based sedative and analgesic effects, mediated by activation of α2 catecholamine receptors, si otú a na-eme ka nzaghachi nzaghachi na-adịghị mma, na-ebelata mmepụta nke neurotransmitters excitatory.
Nkọwapụta (ọkọlọtọ n'ụlọ)
| Ihe | Nkọwapụta |
| Ọdịdị | Na-acha ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ọcha crystalline ma ọ bụ ntụ ntụ |
| Solubility | Soluble na mmiri, methanol na DMSO |
| Ebe mgbaze | 158 ℃ ~ 162 ℃ |
| njirimara | NMR |
| Kachasị adịghị ọcha otu | ≤0.2% |
| Mkpokọta adịghị ọcha | ≤1.0% |
| Mmiri (KF) | ≤1.0% |
| Ihe fọdụrụ na mgbanye | ≤0.10% |
| Acetone | ≤0.5% |
| Methanol | ≤0.3% |
| Ethyl acetate | ≤0.5% |
| Tetrahydrofuran | ≤0.072% |
| Nyocha | Nwere 98.0%-102.0% nke C12H14N2.HCl (Na anhydrous ndabere) |
